FDA Inspection 1239742 — Apitoria Research Centre (A Division of Apitoria Pharma Private Limited)
The FDA completed an inspection of Apitoria Research Centre (A Division of Apitoria Pharma Private Limited) on May 24, 2024 in Sangareddy. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 24, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Sangareddy (India)
Citations
| ID | CFR | Description |
|---|---|---|
| 1270 | 21 CFR 211.68(b) | input/output verification |